Literature DB >> 26941447

A Review of Integrative Medicine in Gynaecological Oncology.

M Kalder1, T Müller2, D Fischer3, A Müller4, W Bader5, M W Beckmann6, C Brucker7, C C Hack6, V Hanf8, A Hasenburg9, A Hein6, S Jud6, M Kiechle10, E Klein10, D Paepke10, A Rotmann11, F Schütz12, G Dobos13, P Voiß13, S Kümmel13.   

Abstract

In recent years complementary and alternative medicine (CAM) has increasingly been the focus of international research. Numerous subsidised trials (7903) and systematic reviews (651) have been published, and the evidence is starting to be integrated into treatment guidelines. However, due to insufficient evidence and/or insufficient good quality evidence, this has mostly not translated to practice recommendations in reviews by the Cochrane collaboration gynaecology group. There is nevertheless a not insignificant number of CAM providers and users. The percentage of oncology patients who use CAM varies between 5 and 90 %. Doctors have been identified as the main providers of CAM. Half of gynaecologists offer CAM because of personal conviction or on suggestion from colleagues. This must be viewed in a critical light, since CAM is mostly practiced without appropriate training, often without sufficient evidence for a given method - and where evidence exists, practice guidelines are lacking - and lack of safety or efficacy testing. The combination of patient demand and lucrativeness for doctors/alternative medicine practitioners, both based on supposed effectiveness CAM, often leads to its indiscriminate use with uncertain outcomes and significant cost for patients. On the other hand there is published, positive level I evidence for a number of CAM treatment forms. The aim of this article is therefore to review the available evidence for CAM in gynaecological oncology practice. The continued need for research is highlighted, as is the need to integrate practices supported by good evidence into conventional gynaecological oncology.

Entities:  

Keywords:  complementary medicine; evidence; gynecology; integrative medicine; oncology

Year:  2016        PMID: 26941447      PMCID: PMC4771505          DOI: 10.1055/s-0042-100208

Source DB:  PubMed          Journal:  Geburtshilfe Frauenheilkd        ISSN: 0016-5751            Impact factor:   2.915


  63 in total

1.  Natural remedy use in a prospective cohort of breast cancer patients in southern Sweden.

Authors:  Maria Hietala; Maria Henningson; Christian Ingvar; Per-Ebbe Jönsson; Carsten Rose; Helena Jernström
Journal:  Acta Oncol       Date:  2010-05-25       Impact factor: 4.089

2.  A comparison of complementary and alternative medicine use by gynecology and gynecologic oncology patients.

Authors:  V E Von Gruenigen; L J White; M S Kirven; A L Showalter; M P Hopkins; E L Jenison
Journal:  Int J Gynecol Cancer       Date:  2001 May-Jun       Impact factor: 3.437

3.  Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.

Authors:  Eunyoung Kang; Eun Joo Yang; Sun-Mi Kim; Il Yong Chung; Sang Ah Han; Do-Hoon Ku; Soek-Jin Nam; Jung-Hyun Yang; Sung-Won Kim
Journal:  Support Care Cancer       Date:  2011-01-28       Impact factor: 3.603

4.  Mindfulness-based stress reduction for breast cancer-a systematic review and meta-analysis.

Authors:  H Cramer; R Lauche; A Paul; G Dobos
Journal:  Curr Oncol       Date:  2012-10       Impact factor: 3.677

Review 5.  The National Cancer Institute's perspective and agenda for promoting awareness and research on alternative therapies for cancer.

Authors:  Jeffrey D White
Journal:  J Altern Complement Med       Date:  2002-10       Impact factor: 2.579

6.  Prevalence and predictors of complementary therapy use in advanced-stage breast cancer patients.

Authors:  Abigail M Gross; Qin Liu; Susan Bauer-Wu
Journal:  J Oncol Pract       Date:  2007-11       Impact factor: 3.840

7.  Use of complementary and alternative medicine in cancer patients: a European survey.

Authors:  A Molassiotis; P Fernández-Ortega; D Pud; G Ozden; J A Scott; V Panteli; A Margulies; M Browall; M Magri; S Selvekerova; E Madsen; L Milovics; I Bruyns; G Gudmundsdottir; S Hummerston; A M-A Ahmad; N Platin; N Kearney; E Patiraki
Journal:  Ann Oncol       Date:  2005-02-02       Impact factor: 32.976

8.  Case-control study of green tea consumption and the risk of endometrial endometrioid adenocarcinoma.

Authors:  Yukika Kakuta; Naoki Nakaya; Satoru Nagase; Megumi Fujita; Toshimitsu Koizumi; Chikako Okamura; Hitoshi Niikura; Kaori Ohmori; Shinichi Kuriyama; Toru Tase; Kiyoshi Ito; Yuko Minami; Nobuo Yaegashi; Ichiro Tsuji
Journal:  Cancer Causes Control       Date:  2008-12-09       Impact factor: 2.506

9.  Proportion of gynecologic cancer patients using complementary and alternative medicine.

Authors:  Amornrat Supoken; Thitima Chaisrisawatsuk; Bandit Chumworathayi
Journal:  Asian Pac J Cancer Prev       Date:  2009

10.  Integrative oncology for breast cancer patients: introduction of an expert-based model.

Authors:  Gustav J Dobos; Petra Voiss; Ilka Schwidde; Kyung-Eun Choi; Anna Paul; Barbara Kirschbaum; Felix J Saha; Sherko Kuemmel
Journal:  BMC Cancer       Date:  2012-11-21       Impact factor: 4.430

View more
  7 in total

1.  Protocol for the process evaluation of a counselling intervention designed to educate cancer patients on complementary and integrative health care and promote interprofessional collaboration in this area (the CCC-Integrativ study).

Authors:  Jasmin Bossert; Cornelia Mahler; Ursula Boltenhagen; Anna Kaltenbach; Daniela Froehlich; Joachim Szecsenyi; Michel Wensing; Stefanie Joos; Nadja Klafke
Journal:  PLoS One       Date:  2022-05-13       Impact factor: 3.752

2.  Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients.

Authors:  Nikolas Schuerger; Evelyn Klein; Alexander Hapfelmeier; Marion Kiechle; Christine Brambs; Daniela Paepke
Journal:  Breast Care (Basel)       Date:  2018-10-23       Impact factor: 2.860

3.  Gynecologic oncologists' attitudes and practices relating to integrative medicine: results of a nationwide AGO survey.

Authors:  Evelyn Klein; Matthias W Beckmann; Werner Bader; Cosima Brucker; Gustav Dobos; Dorothea Fischer; Volker Hanf; Annette Hasenburg; Sebastian M Jud; Matthias Kalder; Marion Kiechle; Sherko Kümmel; Andreas Müller; Myrjam-Alice T Müller; Daniela Paepke; Andre-Robert Rotmann; Florian Schütz; Anton Scharl; Petra Voiss; Markus Wallwiener; Claudia Witt; Carolin C Hack
Journal:  Arch Gynecol Obstet       Date:  2017-06-08       Impact factor: 2.344

4.  Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany.

Authors:  Donata Grimm; Sofia Mathes; Linn Woelber; Caroline Van Aken; Barbara Schmalfeldt; Volkmar Mueller; Marion Kiechle; Christine Brambs; Daniela Paepke
Journal:  Arch Gynecol Obstet       Date:  2020-12-02       Impact factor: 2.344

5.  Active Participation, Mind-Body Stabilization, and Coping Strategies with Integrative Medicine in Breast Cancer Patients.

Authors:  Anna-Katharin Theuser; Sophia Antoniadis; Hanna Langemann; Sonja Wasner; Katharina Grasruck; Svenja Dietzel-Drentwett; Peter A Fasching; Matthias W Beckmann; Carolin C Hack
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

Review 6.  Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone - efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment.

Authors:  Petra Schnell-Inderst; Caroline Steigenberger; Marcel Mertz; Ilvie Otto; Magdalena Flatscher-Thöni; Uwe Siebert
Journal:  Ger Med Sci       Date:  2022-07-14

7.  Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany.

Authors:  Donata Grimm; Petra Voiss; Daniela Paepke; Johanna Dietmaier; Holger Cramer; Sherko Kümmel; Matthias W Beckmann; Linn Woelber; Barbara Schmalfeldt; Ulrich Freitag; Matthias Kalder; Markus Wallwiener; Anna-Katharin Theuser; Carolin C Hack
Journal:  Arch Gynecol Obstet       Date:  2020-11-17       Impact factor: 2.344

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.